An international team of scientists led by a Cedars-Sinai investigator has identified a genetic mutation that appears to protect people from developing Type 2 diabetes.
News & Notes
Researchers have conducted an in-depth evaluation of the genetics of inflammatory bowel disease (IBD) in African-Americans — the first study of its kind, as most research on IBD has been conducted on Caucasian and Asian populations.
An injection of stem cells into the eye may slow or reverse the effects of early-stage, age-related macular degeneration, according to new research from scientists at Cedars-Sinai.
Cedars-Sinai’s new Biobank and Translational Core facility can store millions of tissue and blood samples for analysis using highly advanced technology.
Investigators have developed a method to recreate brain and intestinal cells from patients who died decades ago. Using stored blood samples, these scientists are breaking new ground in the study of debilitating illnesses such as spinal muscular atrophy and inflammatory Read On
Three vaccines have been approved for human papillomavirus (HPV) — but the newest one may be the best for protecting against HPV-related cancers. The vaccine, 9-Valent, could prevent 80 percent of cervical cancers in the United States if given to Read On
A clinical trial is underway at Cedars-Sinai to fight one of the deadliest types of cancer: locally advanced pancreatic cancer, which has an abysmally low five-year survival rate of just 6 percent. To move the needle toward longer survival and Read On